OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuro-Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	66
A practical guide to neuro-oncology fellowship	55
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	54
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	47
Prognostic factors among patients with brain metastases from cancer of unknown primary site	46
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	42
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	42
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	41
Factors influencing timely diagnosis in neurolymphomatosis	40
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	39
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	34
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	34
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	33
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	33
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	31
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	30
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis	30
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	30
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	30
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	29
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	29
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	28
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	28
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	28
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	27

Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	27
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	27